<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35379930</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5438</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of human genetics : EJHG</Title><ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Predictive genetic testing for Motor neuron disease: time for a guideline?</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>636</EndPage><MedlinePgn>635-636</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-022-01093-y</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McNeill</LastName><ForeName>Alisdair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, the University of Sheffield, 385A Glossop Road, Sheffield, S10 2HQ, UK. a.mcneill@sheffield.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amador</LastName><ForeName>Maria-Del-Mar</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA de Paris, Assistance Publique-H&#xf4;pitaux de Paris, Sorbonne Universit&#xe9; Hospital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekker</LastName><ForeName>Hilary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Leeds Unit of Complex Intervention Development (LUCID), Leeds Institute of Health Science, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Angus</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1200-9286</Identifier><AffiliationInfo><Affiliation>Medical Genetics, School of Medicine, Cardiff University, Wales, CF10 3AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crook</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5578-0460</Identifier><AffiliationInfo><Affiliation>Centre for MND Research, Department of Biomedical Science, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>International Aliance of ALS/MND Associations, Northampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEwen</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Health, University of Technology Sydney, Chippendale, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, the University of Sheffield, 385A Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarrell</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, the University of Sheffield, 385A Glossop Road, Sheffield, S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renieri</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0846-9220</Identifier><AffiliationInfo><Affiliation>Medical Genetics, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roggenbuck</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology and Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43212, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmon</LastName><ForeName>Kristiana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology &amp; Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volk</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University Medical Center Hamburg Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Neurodegeneration, Department of Neurology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Alliance of ALS/MND Associations</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Hum Genet</MedlineTA><NlmUniqueID>9302235</NlmUniqueID><ISSNLinking>1018-4813</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35379930</ArticleId><ArticleId IdType="pmc">PMC9177585</ArticleId><ArticleId IdType="doi">10.1038/s41431-022-01093-y</ArticleId><ArticleId IdType="pii">10.1038/s41431-022-01093-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. 22 Years of predictive testing for Huntington&#x2019;s disease: the experience of the UK Huntington&#x2019;s Prediction Consortium. Eur J Hum Genet. 2016;24:1396&#x2013;402. doi: 10.1038/ejhg.2016.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.36</ArticleId><ArticleId IdType="pmc">PMC5027682</ArticleId><ArticleId IdType="pubmed">27165004</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Restagno G, Stewart HG, Chi&#xf2; A. Disease penetrance in amyotrophic lateral sclerosis associated with mutations in the SOD1 gene. Ann Neurol. 2004;55:298&#x2013;9. doi: 10.1002/ana.10850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10850</ArticleId><ArticleId IdType="pubmed">14755739</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;30. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J, McHutchison C, Postuma RB, Boeve BF, Petersen R, et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain. 2021;22:awab404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967095</ArticleId><ArticleId IdType="pubmed">34677606</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador MDM, Gargiulo M, Boucher C, Herson A, Staraci S, Salachas F, et al. Who and Why? Requests for presymptomatic genetic testing for amyotrophic lateral sclerosis/frontotemporal dementia vs Huntington Disease. Neurol Genet. 2020;7:e538. doi: 10.1212/NXG.0000000000000538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000538</ArticleId><ArticleId IdType="pmc">PMC7768924</ArticleId><ArticleId IdType="pubmed">33376800</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanos JH, Gronka S, Wuu J, Stanislaw C, Andersen PM, Benatar M. Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genet Med. 2011;13:342&#x2013;8. doi: 10.1097/GIM.0b013e318204d004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GIM.0b013e318204d004</ArticleId><ArticleId IdType="pmc">PMC4039017</ArticleId><ArticleId IdType="pubmed">21285887</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&#x2019;s disease chromosomes. Cell. 1993;72:971&#x2013;83. doi: 10.1016/0092-8674(93)90585-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90585-E</ArticleId><ArticleId IdType="pubmed">8458085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadasa T, Scaber J, Edmond E, Marsden R, Thompson A, Talbot K et al. Genetic testing in motor neurone disease. Pract Neurol. 2022;13:practneurol-2021-002989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938673</ArticleId><ArticleId IdType="pubmed">35027459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77:100&#x2013;13. doi: 10.1002/ana.24306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook A, Jacobs C, Newton-John T, Richardson E, McEwen A. Patient and relative experiences and decision-making about genetic testing and counseling for familial ALS and FTD: a systematic scoping review. Alzheimer Dis Assoc Disord. 2021;35:374&#x2013;85. doi: 10.1097/WAD.0000000000000458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000458</ArticleId><ArticleId IdType="pubmed">34054018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>